• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

化脓性汗腺炎患者的疼痛管理。

Pain management in patients with hidradenitis suppurativa.

机构信息

Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Department of Dermatology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S47-51. doi: 10.1016/j.jaad.2015.07.046.

DOI:10.1016/j.jaad.2015.07.046
PMID:26470616
Abstract

Hidradenitis suppurativa (HS) is a chronic, relapsing, and painful inflammatory disease. HS patients' quality of life is severely impaired, and this impairment correlates strongly with their pain. Pain in HS can be acute or chronic and has both inflammatory and noninflammatory origins. The purpose of this review is to provide a summary of the existing literature regarding pain management in patients with HS. While there are no formal studies investigating pain management in HS, existing recommendations are based on general pain guidelines and expert opinion. Documentation of pain requires an assessment of the severity and timing of the pain. Although anti-inflammatory drugs and surgery for HS can alleviate pain, adjunctive pain medications are typically necessary. Topical analgesics, oral acetaminophen, and oral nonsteroidal anti-inflammatory drugs are considered first-line agents for the treatment of pain in patients with HS. If pain management is ineffective with those agents, oral opiates can be considered. In addition, anticonvulsants and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors possess neuropathic pain-relieving properties that offer not only control of HS-associated pain but beneficial effects on itch and depression. There is clearly a need for additional studies on pain management in patients with HS.

摘要

化脓性汗腺炎(HS)是一种慢性、复发性、疼痛性炎症性疾病。HS 患者的生活质量严重受损,这种损害与他们的疼痛密切相关。HS 患者的疼痛可以是急性的,也可以是慢性的,既有炎症性的,也有非炎症性的。本综述的目的是总结有关 HS 患者疼痛管理的现有文献。虽然没有正式研究调查 HS 中的疼痛管理,但现有的建议是基于一般疼痛指南和专家意见。疼痛的记录需要评估疼痛的严重程度和发生时间。虽然 HS 的抗炎药物和手术可以缓解疼痛,但通常需要辅助止痛药物。局部镇痛药、口服对乙酰氨基酚和口服非甾体抗炎药被认为是治疗 HS 患者疼痛的一线药物。如果这些药物对疼痛管理无效,可以考虑口服阿片类药物。此外,抗惊厥药和选择性 5-羟色胺再摄取抑制剂/5-羟色胺去甲肾上腺素再摄取抑制剂具有缓解神经性疼痛的特性,不仅可以控制与 HS 相关的疼痛,还可以对瘙痒和抑郁产生有益的影响。显然,需要对 HS 患者的疼痛管理进行更多的研究。

相似文献

1
Pain management in patients with hidradenitis suppurativa.化脓性汗腺炎患者的疼痛管理。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S47-51. doi: 10.1016/j.jaad.2015.07.046.
2
Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine.使用非甾体抗炎药、对乙酰氨基酚、塞来昔布、加巴喷丁、普瑞巴林、度洛西汀和文拉法辛治疗化脓性汗腺炎相关疼痛。
Dermatol Online J. 2013 Nov 15;19(11):20616.
3
Hidradenitis suppurativa in the pediatric population.儿童人群中的化脓性汗腺炎。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S36-41. doi: 10.1016/j.jaad.2015.07.051.
4
Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa.口服葡萄糖酸锌与外用三氯生联合应用:一种治疗初发性化脓性汗腺炎的抗炎治疗方式。
J Dermatol Sci. 2016 Nov;84(2):197-202. doi: 10.1016/j.jdermsci.2016.08.010. Epub 2016 Aug 10.
5
Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment.评估化脓性汗腺炎临床应答(HiSCR)作为化脓性汗腺炎治疗的临床终点的有效性、反应性和有意义性。
Br J Dermatol. 2014 Dec;171(6):1434-42. doi: 10.1111/bjd.13270. Epub 2014 Nov 11.
6
Local wound care and topical management of hidradenitis suppurativa.局部伤口护理和化脓性汗腺炎的局部治疗。
J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S55-61. doi: 10.1016/j.jaad.2015.07.048.
7
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.间苯二酚焕肤术作为一种治疗化脓性汗腺炎疼痛性结节的可能的自我疗法。
Clin Exp Dermatol. 2010 Jan;35(1):36-40. doi: 10.1111/j.1365-2230.2009.03377.x. Epub 2009 Jun 22.
8
Topical treatments of skin pain: a general review with a focus on hidradenitis suppurativa with topical agents.皮肤疼痛的局部治疗:以外用药物治疗化脓性汗腺炎为重点的综述
Dermatol Online J. 2014 Jul 15;20(7):13030/qt4m57506k.
9
Hidradenitis suppurativa: A practical review of possible medical treatments based on over 350 hidradenitis patients.化脓性汗腺炎:基于350多名化脓性汗腺炎患者对可能的药物治疗的实用综述
Dermatol Online J. 2013 Apr 15;19(4):1.
10
Pain management in hidradenitis suppurativa and a proposed treatment algorithm.化脓性汗腺炎的疼痛管理及治疗方案建议
J Am Acad Dermatol. 2021 Jul;85(1):187-199. doi: 10.1016/j.jaad.2020.09.039. Epub 2020 Sep 17.

引用本文的文献

1
Impaired Molecular Mechanisms Contributing to Chronic Pain in Patients with Hidradenitis Suppurativa: Exploring Potential Biomarkers and Therapeutic Targets.化脓性汗腺炎患者慢性疼痛相关分子机制受损:探索潜在生物标志物和治疗靶点。
Int J Mol Sci. 2025 Jan 25;26(3):1039. doi: 10.3390/ijms26031039.
2
Management of hidradenitis suppurativa in the inpatient setting: a clinical guide.住院环境下化脓性汗腺炎的管理:临床指南
Arch Dermatol Res. 2025 Jan 8;317(1):202. doi: 10.1007/s00403-024-03622-9.
3
Essentials of hidradenitis suppurativa: a comprehensive review of diagnostic and treatment perspectives.
化脓性汗腺炎要点:诊断与治疗观点的全面综述
Ann Med Surg (Lond). 2024 Jul 1;86(9):5304-5313. doi: 10.1097/MS9.0000000000002345. eCollection 2024 Sep.
4
Hidradenitis suppurativa - biologic therapy and other available treatment options.化脓性汗腺炎——生物治疗及其他可用的治疗选择。
Postepy Dermatol Alergol. 2023 Aug;40(4):518-528. doi: 10.5114/ada.2021.112075. Epub 2022 Jan 18.
5
Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa.疼痛评估在疼痛性皮肤疾病和类风湿关节炎随机对照试验中的应用:一项范围综述,旨在为化脓性汗腺炎的疼痛评估提供信息。
Br J Dermatol. 2022 Dec;187(6):846-854. doi: 10.1111/bjd.21821. Epub 2022 Sep 4.
6
Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.化脓性汗腺炎/反向性痤疮中的瘙痒:一项系统评价
J Clin Med. 2022 Jun 30;11(13):3813. doi: 10.3390/jcm11133813.
7
Adalimumab Effect on Pain in Hidradenitis Suppurativa Patients: Systematic Review and Meta-Analysis.阿达木单抗对化脓性汗腺炎患者疼痛的影响:系统评价与荟萃分析
Dermatol Pract Concept. 2022 Apr 1;12(2):e2022099. doi: 10.5826/dpc.1202a99. eCollection 2022 May.
8
Pain as Defining Feature of Health Status and Prominent Therapeutic Target in Patients with Hidradenitis Suppurativa.疼痛作为化脓性汗腺炎患者健康状况的定义特征及突出治疗靶点。
J Clin Med. 2021 Aug 18;10(16):3648. doi: 10.3390/jcm10163648.
9
Hidradenitis Suppurativa: Where We Are and Where We Are Going.化脓性汗腺炎:现状与未来。
Cells. 2021 Aug 15;10(8):2094. doi: 10.3390/cells10082094.
10
Hidradenitis suppurativa: Basic considerations for its approach: A narrative review.化脓性汗腺炎:诊疗的基本考量:一篇叙述性综述
Ann Med Surg (Lond). 2021 Aug 5;68:102679. doi: 10.1016/j.amsu.2021.102679. eCollection 2021 Aug.